Skip to search formSkip to main contentSkip to account menu

idoxifene

Known as: Pyr-I-Tam, 4-iodopyrrolidinotamoxifen, 1-[2-[4-[(1E)-1-(4-Iodophenyl)-2-phenyl-1-butenyl]phenoxy]ethyl]pyrrolidine 
A drug that blocks the effects of estrogen.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
The estrogen receptor alpha (ERalpha) has proven to be the single most important target in breast cancer over the last 30 years… 
Review
2005
Review
2005
Review
2004
Review
2004
Review
2001
Review
2001
  • M. Dowsett
  • Endocrine-related cancer
  • 2001
  • Corpus ID: 1510886
Hormonal therapy leads to improved survival in oestrogen receptor (ER) positive early breast cancer and long-term responses in… 
Highly Cited
2001
Highly Cited
2001
In experimental models, human epidermal growth factor receptor-2 (HER-2) amplification leads to estrogen independence and… 
Highly Cited
1999
Highly Cited
1999
Antiestrogens such as tamoxifen are one of the most effective methods of treating estrogen receptor (ERa) positive breast cancers… 
Highly Cited
1998
Highly Cited
1998
We have discovered a new, nonsteroidal, potent estrogen agonist/antagonist, CP-336,156. CP-336,156 binds selectively and with… 
Highly Cited
1995
Highly Cited
1995
Idoxifene, a novel antiestrogen with reduced estrogenic activity when compared to tamoxifen, has been given to 20 women with…